Arsanis Inc. (ASNS)

1.87 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 1.87

Price Open 2.18

Volume: 874

Avg Volume: 173,340

Market Cap: 26.77M

P/E Ratio -0.57

52 Wk Range 1.71-28.6942



ASNS Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
13.63M
120,919
0.73
0.89%

2018-07-13
13.63M
129,456
0.67
0.95%

2018-06-29
13.63M
245,183
1.98
1.80%

2018-06-15
13.63M
207,096
5.80
1.52%




ASNS Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-06-08
Q1 2018
N/A
-1.24 (2)
0.00
0.00

2018-05-10
Q1 2018
N/A
-1.24 (2)
-0.74
0.50

2018-03-09
Q4 2017
N/A
-3.05 (1)
-1.68
1.37

News

Midday Gainers / Losers (08/16/2018) (2018-08-16 12:37 SeekingAlpha)

Gainers: JMU +98% . XRF +25% . ANW +18% . LFVN +16% . NFEC +15% . PETQ +15% . GSM +15% . LYTS +15% . RVLT +14% . SPCB +13% . More news on: JMU Limited, China Rapid Finance, Aegean Marine Petroleum Network Inc., Stocks on the move, , Read more …

 

Premarket Losers as of 9:05 am (8/16/2018) (2018-08-16 09:11 SeekingAlpha)

PTIE -50% on announcing $11.3M direct offering. More news on: Pain Therapeutics, J.C. Penney Company Inc., MiMedx Group Inc., Stocks on the move, , Read more …

 


Statistics

Shares Outstanding: 14.32M

Top 15 Institution Percent: 71.00

Price To Sales: N/A

Price To Book: 0.84

Revenue: N/A

Gross Profit: N/A

Cash: 26.25M

Debt: 12.52M

Return On Assets: -79.66

Return On Equity: -120.68

Profit Margin: N/A

Price History

Beta: -5.25

50-day Moving Avg: 7.51

200-day Moving Avg: 14.22

YTD Change: -84.40

5-day Change: -17.26

1-month Change: -43.33

3-month Change: -90.61

6-month Change: -86.42

1-year Change: -86.67

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Arsanis Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.arsanis.com

Arsanis Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of monoclonal antibodies for the targeted immunotherapy of serious infections.